Bronchial Diseases Withdrawn Phase 2 Trials for PF-00610355 (DB11871)

Also known as: Bronchial Disease

IndicationStatusPhase
DBCOND0042791 (Bronchial Diseases)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00830427A Study To Examine The Safety And Efficacy Of PF-00610355 In Moderately Asthmatic SubjectsTreatment